Further tests are needed but a trial showed that, when compared against placebo treatment, those given the drug had a 79% lower risk of developing severe disease.
Articles on drug trial
Displaying all articles
Preliminary results indicate dexamethasone could help treat severely ill patients in hospital with COVID-19. But it’s early days yet.
Deliberately infecting people with a disease-causing agent as part of carefully considered medical research can be ethically acceptable or even necessary.
Top contributors
-
Professor of Pharmaceutical Chemistry, Macquarie University
-
Professor of Bioethics, Monash Bioethics Centre, Monash University, Monash University
-
Pharmacist and PhD Candidate, University of Sydney
-
Infectious Disease Ethics Fellow, Ethox & Wellcome Centre for Ethics and Humanities, Univeristy of Oxford. Adjunct, Monash University